Search results for " Systemic Inflammatory Response Syndrome"

showing 4 items of 4 documents

Cardiac surgery outcomes in patients with coronavirus disease 2019 (COVID-19): A case-series report

2020

Abstract Objective The impact of coronavirus disease 2019 (COVID-19) on the postoperative course of patients after cardiac surgery is unknown. We experienced a major severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in our cardiac surgery unit, with several patients who tested positive early after surgery. Here we describe the characteristics, postoperative course, and laboratory findings of these patients, along with the fate of the health care workers. We also discuss how we reorganize and reallocate hospital resources to resume the surgical activity without further positive patients. Methods After diagnosis of the first symptomatic patient, surgery was suspended. Naso…

AdultMalePulmonary and Respiratory MedicineSIRS systemic inflammatory response syndromemedicine.medical_specialtyInfectious Disease Transmission Patient-to-ProfessionalCoronavirus disease 2019 (COVID-19)Sars-CoV-2medicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)cardiac surgery COVID-19 new coronavirus SARS-CoV-2CRP C-reaction protein030204 cardiovascular system & hematologyHealth Services AccessibilityArticleDisease OutbreaksTertiary Care Centers03 medical and health sciences0302 clinical medicinePostoperative ComplicationsValve replacementInterquartile rangeInternal medicineHealth caremedicineHumansIn patientCardiac Surgical ProceduresAgedAged 80 and overInfection ControlHealth Care RationingTAVR transcatheter aortic valve replacementbusiness.industrynew coronavirusExtracorporeal circulationCOVID-19Middle AgedCardiac surgery030228 respiratory systemItalyRT-PCR t real-time reverse transcription polymerase chain reactionFemaleSurgeryCOVID-19 / Sars-CoV-2 novel coronavirus 2businessCardiology and Cardiovascular Medicinecardiac surgeryFollow-Up Studies
researchProduct

Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in…

2021

Abstract Background There is mounting evidence on the existence of a Pediatric Inflammatory Multisystem Syndrome-temporally associated to SARS-CoV-2 infection (PIMS-TS), sharing similarities with Kawasaki Disease (KD). The main outcome of the study were to better characterize the clinical features and the treatment response of PIMS-TS and to explore its relationship with KD determining whether KD and PIMS are two distinct entities. Methods The Rheumatology Study Group of the Italian Pediatric Society launched a survey to enroll patients diagnosed with KD (Kawasaki Disease Group – KDG) or KD-like (Kawacovid Group - KCG) disease between February 1st 2020, and May 31st 2020. Demographic, clini…

Coronary artery abnormalities; Hypotension; Kawasaki disease; Multisystem inflammatory syndrome associated with coronavirus disease; Myocarditis; Pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection; SARS-CoV-2; Age Distribution; Antirheumatic Agents; Aspirin; C-Reactive Protein; COVID-19; Child; Child Preschool; Coronary Artery Disease; Cough; Diarrhea; Dyspnea; Female; Glucocorticoids; Heart Failure; Humans; Hyperferritinemia; Hypotension; Immunoglobulins Intravenous; Immunologic Factors; Infant; Intensive Care Units Pediatric; Interleukin 1 Receptor Antagonist Protein; Italy; Lymphopenia; Male; Mucocutaneous Lymph Node Syndrome; Myocarditis; Platelet Aggregation Inhibitors; SARS-CoV-2; Shock; Systemic Inflammatory Response Syndrome; Tachypnea; Troponin T; VomitingMalelcsh:Diseases of the musculoskeletal systemcoronary artery abnormalities; hypotension; kawasaki disease; multisystem inflammatory syndrome associated with coronavirus disease; myocarditis; pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection; SARS-CoV-2; age distribution; antirheumatic agents; aspirin; C-reactive protein; COVID-19; child ; preschool; coronary artery disease; cough; diarrhea; yspnea; female; glucocorticoids; heart failure; humans; hyperferritinemia; hypotension; immunoglobulins; intravenous; immunologic factors; infant; intensive care units; pediatric; interleukin 1 receptor antagonist protein; italy; lymphopenia; male; mucocutaneous lymph node syndrome; myocarditis; platelet aggregation inhibitors; SARS-CoV-2; shock; systemic inflammatory response syndrome; tachypnea; troponin T; vomitingMyocarditiCoronary Artery Disease030204 cardiovascular system & hematologySARS-CoV-2 Kawasaki disease Pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection Myocarditis Hypotension Multisystem inflammatory syndrome associated with coronavirus disease Coronary artery abnormalitiesCoronary artery diseaseSettore MED/38 - Pediatria Generale E Specialistica0302 clinical medicineGlucocorticoidImmunologic FactorMultisystem inflammatory syndrome associated with coronavirus diseaseImmunology and AllergyChildCoronary artery abnormalitieFisher's exact testPediatricTachypneabiologylcsh:RJ1-570Antirheumatic AgentImmunoglobulins IntravenousShockPediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infectionSettore MED/38Systemic Inflammatory Response SyndromeIntensive Care UnitsMyocarditisC-Reactive ProteinItalyAntirheumatic AgentsChild PreschoolCohortsymbolsPlatelet aggregation inhibitorFemaleHypotensionIntravenousCoronary artery abnormalitiesHumanResearch ArticleDiarrheamedicine.medical_specialtyMyocarditisVomitingImmunoglobulinsMucocutaneous Lymph Node SyndromeIntensive Care Units Pediatric03 medical and health sciencessymbols.namesakeAge DistributionRheumatologyTroponin TInternal medicineLymphopeniamedicineHumansImmunologic FactorsPreschoolGlucocorticoids030203 arthritis & rheumatologyHeart FailureAspirinKawasaki diseasebusiness.industrySARS-CoV-2Platelet Aggregation InhibitorC-reactive proteinCOVID-19Infantlcsh:Pediatricsmedicine.diseaseSystemic inflammatory response syndromeInterleukin 1 Receptor Antagonist ProteinDyspneaCoughImmunoglobulins IntravenouPediatrics Perinatology and Child Healthbiology.proteinKawasaki diseaseHyperferritinemialcsh:RC925-935businessPlatelet Aggregation InhibitorsPediatric rheumatology online journal
researchProduct

Factors Associated With Severe Gastrointestinal Diagnoses in Children With SARS-CoV-2 Infection or Multisystem Inflammatory Syndrome

2021

Key Points Question Is COVID-19 associated with severe gastrointestinal manifestations in children? Findings In this multicenter cohort study of 685 Italian children with COVID-19, 10% showed severe gastrointestinal involvement characterized by diffuse adeno-mesenteritis, appendicitis, abdominal fluid collection, ileal intussusception, or pancreatitis. Children older than 5 years and those presenting with abdominal pain, leukopenia, or receiving a diagnosis of multisystem inflammatory syndrome were more likely to have severe gastrointestinal manifestations. Meaning Severe gastrointestinal involvement is not uncommon in children with COVID-19, and awareness about its frequency and presentati…

MaleGastrointestinalPrognosiGastrointestinal DiseasesGastrointestinal DiseaseMultisystem Inflammatory SyndromeCOVID-19; Child; Child Preschool; Female; Gastrointestinal Diseases; Humans; Male; Prognosis; Radiography; Retrospective Studies; SARS-CoV-2; Systemic Inflammatory Response Syndromemacromolecular substancesSarsCoV2PediatricsRetrospective StudieHumansChildPreschoolChildrenOriginal InvestigationRetrospective StudiesSARS-CoV-2ResearchGastrointestinal Children SARS-CoV-2 Multisystem Inflammatory SyndromeCOVID-19General MedicinePrognosisSettore MED/38gastrointestinalSystemic Inflammatory Response SyndromeRadiographyOnline OnlyChild PreschoolFemaleSarsCoV2; COVID-19; gastrointestinalHuman
researchProduct

A 7-Year-Old Boy and a 14-Year-Old Girl Initially Diagnosed with Toxic Shock Syndrome and Tested Positive for SARS-CoV-2 Infection, Supporting a Diag…

2021

Case series Patients: Male, 7-year-old • Female, 14-year-old Final Diagnosis: Multisystem inflammatory syndrome in children (MIS-C) Symptoms: Muscular weakness • shock Medication: — Clinical Procedure: — Specialty: Critical Care Medicine • Infectious Diseases • Pediatrics and Neonatology • Rheumatology Objective: Unusual clinical course Background: Multisystem inflammatory syndrome in children (MIS-C) has recently been described in children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This report describes 2 children with MIS-C who were initially diagnosed with toxic shock syndrome but who tested positive for SARS-CoV-2 infection on reverse transcription-polym…

MalePediatricsmedicine.medical_specialtyCOVID-19 Related Immunoglobulins Intravenous Mucocutaneous Lymph Node Syndrome Pediatric Multisystem Inflammatory Disease Adolescent COVID-19 Testing Child Female Humans Male Pandemics SARS-CoV-2 Systemic Inflammatory Response Syndrome COVID-19 Shock SepticAdolescentMucocutaneous Lymph Node SyndromeTachypneaPericardial effusionCOVID-19 TestingOliguriamedicineHumansPediatric Multisystem Inflammatory Disease COVID-19 RelatedChildPandemicsbusiness.industrySARS-CoV-2Toxic shock syndromeImmunoglobulins IntravenousCOVID-19General MedicineArticlesmedicine.diseaseShock SepticSystemic Inflammatory Response SyndromeSystemic inflammatory response syndromePneumoniaMethylprednisoloneMacrophage activation syndromeFemalemedicine.symptombusinessmedicine.drugThe American Journal of Case Reports
researchProduct